📢 New expert consensus on lipids in #ParenteralNutrition is now published! Key highlights from the International Lipid Summit include the importance of fish oil in modern intravenous lipid emulsions for significant clinical benefits. 👉 Stay updated:

@Paucat85 @FreseniusKabiNC Estimado @Paucat85: Gracias por tu mensaje. Póngase en contacto con socialmedia@fresenius-kabi.com por correo electrónico. Nuestros colegas se comunicarán con usted pronto. Atentamente, Su equipo de redes sociales de Fresenius Kabi

@Paucat85 @FreseniusKabiNC 2/2 Le agradeceríamos que nos envíe por mensaje directo una dirección de correo electrónico a través de la cual nuestros colegas puedan contactarle. Muchas gracias por adelantado. Atentamente, Su equipo de redes sociales de Fresenius Kabi

@sinhavivek83 2/2 We will make sure that you will be contacted quickly. ​ Best regards, Your Fresenius Kabi Social Media Team

👶 A key to children's growth and health: #TraceElements play an important role in pediatric parenteral nutrition. 👉 Discover best practices for dosing according to international guidelines: . #Pediatrics #ParenteralNutrition

Missed our session at #ESICM Lives 2024? Get a glimpse of the key discussions in this video. 👉 Watch the full conversation at #CommittedToLife

🎗️ This month, our teams from all over the world are lacing up to raise awareness and stand in solidarity with those affected by breast cancer through a variety of initiatives. These snapshots are capturing their spirit, embodying our commitment to life. #TeamFresenius

Learn more about our innovative energy transformation project and the sustainability award here:

What a great start to #UEGweek in Vienna! 🙌 Haven’t stopped by our booth yet? Come by to explore our #Biosimilars portfolio and visit our symposium “Difficult-To-Treat Crohn’s Disease. From Monotherapy to Dual Targeted Therapy: Towards a New Paradigm?” 📅 TODAY: 5:30 p.m. CEST.

Heading to #UEGWeek? Stop by the Fresenius Kabi booth to explore our biosimilars portfolio and join our symposium “Difficult-To-Treat Crohn’s Disease. From Monotherapy to Dual Targeted Therapy: Towards a New Paradigm?” on October 14 at 5:30 p.m. CEST! #Gastroenterology @my_ueg

Breast cancer is one of the most common cancers in women. Early detection through regular screenings can greatly improve outcomes. 🎗️ Join us in spreading awareness this #BreastCancerAwarenessMonth. #CommittedToLife

Exciting news! Dr. Sandra Emily Stoll from University Hospital Cologne is the recipient of the €20,000 ESICM - Fresenius Kabi Clinical Nutrition Research Award! 🏆 Her study will explore innovative feeding strategies for critically ill patients. #ESICM24 #ClinicalNutrition

Hola from Barcelona! 🙌 Join us at #ESICM24! Meet our experts, explore the latest in MedTech & medical nutrition. Don't miss our symposium "Navigating Nutritional Pathways: Insights from a Patient's Journey." Let’s shape the future of intensive care! 🚑💊 #CommittedToLife @ESICM

📅 We're at #UEGweek, October 12-15, in Vienna. Visit our booth to explore our biosimilars portfolio & attend our symposium: “Difficult-To-Treat Crohn’s Disease. From Monotherapy to Dual Targeted Therapy: Towards a New Paradigm?”, Oct 14, 5:30 p.m. CEST. #Gastroenterology @my_ueg

This October, we honor Breast Cancer Awareness Month. At Fresenius Kabi, we are committed to supporting those affected by providing vital, accessible cancer therapies. Together, we can make a difference in the fight. 🎗️ #BreastCancerAwareness #CommittedToLife

@LisaRDICUMMUH Dear @LisaRDICUMMUH the session will also be recorded and made available as video on demand for all congress participants on the ESICM LIVES mobile app.

@Nelegligee Lieber @Nelegligee, vielen Dank, dass Sie uns kontaktiert haben. Bitte senden Sie uns via Direct Message eine E-Mail Adresse oder Telefonnummer, unter der unsere Kollegen Sie erreichen können. Viele Grüße, Ihr Social Media Team von Fresenius Kabi